Cases & Deals

Nanobiotix completes €21.3 million private placement of new shares

Clients Nanobiotix SA

Jones Day advised Nanobiotix SA, an oncology focused nanomedicine company listed on the regulated market of Euronext in Paris, in connection with its €21.3 million (US$26.1 million) private placement of new shares to U.S. and European investors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.